Invest A/s Lundbeckfond's Net Worth

$41.5 Million

Estimate Recalculated Jul 3, 2024 03:41PM EST

Who is Invest A/s Lundbeckfond?

Invest A/s Lundbeckfond has an estimated net worth of $41.5 Million. This is based on reported shares across multiple companies, which include Lexeo Therapeutics, Inc., Celladon Corp, IO Biotech, Inc., Spero Therapeutics, Inc., Trevi Therapeutics, Inc., scPharmaceuticals Inc., and IMARA Inc..

SEC CIK

Invest A/s Lundbeckfond's CIK is 0001591046

Past Insider Trading and Trends

2023 was Invest A/s Lundbeckfond's most active year for acquiring shares with 5 total transactions. Invest A/s Lundbeckfond's most active month to acquire stocks was the month of October. 2014 was Invest A/s Lundbeckfond's most active year for disposing of shares, totalling 3 transactions. Invest A/s Lundbeckfond's most active month to dispose stocks was the month of October. 2021 saw Invest A/s Lundbeckfond paying a total of $29,999,998.00 for 6,049,452 shares, this is the most they've acquired in one year. In 2014 Invest A/s Lundbeckfond cashed out on 19,666,185 shares for a total of $148,840.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Lexeo Therapeutics, Inc. (LXEO) Snapshot price: $16.29

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.84M
$11.00
—
1.84M
Nov 7
Form 3
—
0
—
—
0
No matching records found

Celladon Corp (EIGR) Snapshot price: $6.4

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.75M
$8.00
—
1.75M
Feb 4
Form 3
—
0
—
—
0
No matching records found

IO Biotech, Inc. (IOBT) Snapshot price: $1.7708

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+130.61%
7.9M
$1.90
$15,012,344.60
13.95M
Aug 9
Form 4
∞
6.05M
$14.00
—
6.05M
Nov 9
Form 3
—
0
—
—
0
No matching records found

Spero Therapeutics, Inc. (SPRO) Snapshot price: $1.43

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Trevi Therapeutics, Inc. (TRVI) Snapshot price: $1.475

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.15M
$10.00
—
1.15M
May 9
Form 3
—
0
—
—
0
No matching records found